Evaluation of the Patient Global Impression of Symptom Severity (PGISS) Score as a Subjective and Objective Measure of Disease Activity in Chronic Rhinosinusitis

Abstract

Background

The Sino-nasal Outcome Test (SNOT-22) is a 22-question survey that is utilized to evaluate health-related quality of life of patients with chronic rhinosinusitis (CRS). The Patient Global Impression Symptom Severity (PGISS) is a similar yet versatile instrument that combines features of both a Likert scale and a visual analog to assess symptom severity in CRS patients. While previous studies have evaluated the validity of SNOT-22 as an instrument to measure CRS patients’ symptom severity, no studies have evaluated PGISS scale's ability to evaluate and guide treatment plans for CRS patients.

Objective

The primary objective of this study was to analyze the clinical utility of PGISS in assessing subjective symptom severity and objective disease status in CRS patients. We additionally aimed to investigate if PGISS scores could serve as predictors for treatment strategies in CRS patients.

Methods

Electronic medical records of CRS patients were retrospectively reviewed between January 2020 and January 2021 from Eastern Virginia Medical School and Sentara Healthcare. Information on demographics, objective disease metrics, treatment, and labs were collected. Statistical analyses were conducted using SAS 9.4 software.

Results

A total of 150 patients were included in our study. A statistically significant positive correlation was found between PGISS and SNOT-22 scores (r(131) = 0.701, P < .0001). Patients with moderate to severe PGISS scores had significantly higher odds of changing their treatment course (odds ratio [OR] = 6.813, P = .001, and OR = 5.491, P = .018, respectively). Additionally, patients with severe PGISS scores had decreased odds of receiving biological intervention (OR = 0.048, P = .043), but they had considerably higher odds of pursuing surgery (OR = 15.939, P = .046). No significant associations were seen between PGISS scores and receiving topical steroids, systematic steroids, nonsteroidal medical treatment, or imaging interventions (P > .05).

Conclusion

Clinicians may consider using the PGISS scale as an alternative method to the SNOT-22 to evaluate subjective symptom severity and guide treatment plans for patients with CRS.

Keywords

chronic rhinosinusitis rhinosinusitis sinusitis otolaryngology patient global impression of symptom severity PGISS SNOT-22 sinonasal outcome test quality of life healthcare delivery

Get full access to this article

View all access options for this article.

References

Palmer

Messina

Biletch

Grosel

Mahmoud

. A cross-sectional, population-based survey of U.S. adults with symptoms of chronic rhinosinusitis. Allergy Asthma Proc. 2019;40(1):48–56. doi:https://doi.org/10.2500/aap.2019.40.4182

Orlandi

Kingdom

Smith

, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021;11(3):213–739. doi:https://doi.org/10.1002/alr.22741. Erratum in: Int Forum Allergy Rhinol. 2022 Jul;12(7):974. PMID: 33236525.

Sedaghat

Kuan

Scadding

. Epidemiology of chronic rhinosinusitis: prevalence and risk factors. J Allergy Clin Immunol Pract. 2022;10(6):1395–1403. doi:https://doi.org/10.1016/j.jaip.2022.01.016

Kazi

West

Rahman

Kim

Sima

Schuman

. Pain catastrophizing and quality of life in adults with chronic rhinosinusitis. Laryngoscope. 2021;131(9):1939–1945. doi:https://doi.org/10.1002/lary.29405

Gallo

Russo

Mozzanica

, et al. Prognostic value of the Sinonasal Outcome Test 22 (SNOT-22) in chronic rhinosinusitis. Acta Otorhinolaryngol Ital. 2020;40(2):113–121. doi:https://doi.org/10.14639/0392-100X-N0364

Liu

Weitzel

Chen

. The predictive utility of the 22-item Sino-Nasal Outcome Test (SNOT-22): a scoping review. Int Forum Allergy Rhinol. 2022;12(1):83–102. doi:https://doi.org/10.1002/alr.22888

Hopkins

Gillett

Slack

Lund

Browne

. Psychometric validity of the 22-item sinonasal outcome test. Clin Otolaryngol. 2009;34(5):447–454. doi:https://doi.org/10.1111/j.1749-4486.2009.01995.x

Reed

Wolf

Cotton

Dellon

. A visual analogue scale and a Likert scale are simple and responsive tools for assessing dysphagia in eosinophilic oesophagitis. Aliment Pharmacol Ther. 2017;45(11):1443–1448. doi:https://doi.org/10.1111/apt.14061

Toma

Hopkins

. Stratification of SNOT-22 scores into mild, moderate, or severe and relationship with other subjective instruments. Rhinology. 2016;54(2):129–133. doi:https://doi.org/10.4193/Rhino15.072

10.

Doulaptsi

Prokopakis

Seys

Pugin

Steelant

Hellings

. Visual analogue scale for sino-nasal symptoms severity correlates with Sino-Nasal Outcome Test 22: paving the way for a simple outcome tool of CRS burden. Clin Transl Allergy. 2018;8(32):1–5. doi:https://doi.org/10.1186/s13601-018-0219-6

11.

Kennedy

Hubbard

Huyett

Patrie

Borish

Payne

. Sino-Nasal Outcome Test (SNOT-22): A predictor of post-surgical improvement in patients with chronic rhinosinusitis. Ann Allergy Asthma Immunol. 2013;111(4):246–251. doi:https://doi.org/10.1016/j.anai.2013.06.033

12.

House

Arruda

Andrasik

Grazzi

. The reliability and validity of the visual analog mood scales in non-English-speaking pain patients. Pain Pract. 2012;12(8):626–632. doi:https://doi.org/10.1111/j.1533-2500.2012.00544.x

13.

Devraj

Herndon

Griffin

. Pain awareness and medication knowledge: a health literacy evaluation. J Pain Palliat Care Pharmacother. 2013;27(1):19–27. doi:https://doi.org/10.3109/15360288.2012.751955

14.

DeConde

Mace

Bodner

, et al. SNOT-22 quality of life domains differentially predict treatment modality selection in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2014;4(12):972–979. doi:https://doi.org/10.1002/alr.21408